Please provide your email address to receive an email when new articles are posted on . The study comprised 264,590 patients whose eosinophil levels were measured. There were no significant changes in ...

Please provide your email address to receive an email when new articles are posted on . High FeNO levels indicate exacerbation and lung function risks. Most patients with high FeNO levels also had ...

The researchers identified 411 patients with PMF who had baseline basophil and eosinophil counts available at the time of diagnosis or first referral. After a median follow-up of 52 months, most ...

A 33-year-old Hispanic active-duty US Army soldier was referred to our service after being seen at an outside facility with 3.5 weeks of headache, fever, chills, night sweats, and a nonproductive ...

The variants of ARPC1B described in the literature are displayed, with the red-highlighted variant indicating the one identified in our patient. (B) The variant identified in our patient is located in ...

Many people with COPD can control their symptoms by using inhaled medicines each day. But inhaled medicines may not offer enough relief for people who also have high levels of a type of white blood ...

Connect Biopharma Holdings Limited announced promising results from its clinical studies of rademikibart, an investigational anti-IL-4Rα antibody, at the EAACI 2025 Annual Congress. The data show that ...

New research shows PPIs can limit fibrosis in eosinophilic oesophagitis, offering potential disease-modifying effects. Learn more about PPI therapy.

Incidence of colorectal cancer in the republic of Ireland: Trends and challenges. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text ...

What Is Exdensur, and Why Does It Matter? Exdensur (depemokimab) is a new type of ultra long-acting biologic medicine approved by the FDA as an add-on maintenance treatment for severe eosinophilic ...